dihydroergotoxine mesylate in sublingual tablets , 3 mg daily , and in oral tablets , 6 mg daily , respectively , was given for 12 weeks , and therapeutic effects at those doses were compared by a double-blind method .
C0991582
sublingual
C0993159
oral tablets